BetterLife Pharma annual ebitda
2015
2016
BetterLife Pharma's calculated EBITDA was −$10.3M for fiscal 2016.
View full BetterLife Pharma company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2016 | 2016-01-31 | −$10.3M | −$10.2M | — |
| 2015 | 2015-01-31 | −$117,075 | — | — |
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q4 2016 | 2016-01-31 | −$6.8M | — | — |
| Q3 2016 | 2015-10-31 | −$7,756 | — | — |
| Q2 2016 | 2015-07-31 | −$2.4M | — | — |
| Q1 2016 | 2015-04-30 | −$1.2M | — | — |
Across the available reported history, BetterLife Pharma's ebitda decreased from −$117,075 to −$10.3M, a change of −$10.2M. The latest reported quarter, Q4 2016, shows −$6.8M.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BetterLife Pharma filings at SEC.gov ↗